Clinical Research Facility

Paris, Texas 75460

We've found

1 trials

at this facility

A Phase 1 Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (AMBER)

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Paris, TX

Use our guide to learn which trials are right for you!